March 27, 2024
AstraZeneca Japan President Takafumi Horii AstraZeneca’s sales in Japan climbed 8.2% year on year in 2023 with new drug launches and label expansions more than offsetting the negative blow from generic erosions for its proton pump inhibitor Nexium (esomeprazole). The...read more